Logo image of CNNE

CANNAE HOLDINGS INC (CNNE) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CNNE - US13765N1072 - Common Stock

15.85 USD
-0.05 (-0.31%)
Last: 12/26/2025, 4:15:00 PM
15.85 USD
0 (0%)
After Hours: 12/26/2025, 4:15:00 PM
Fundamental Rating

2

Taking everything into account, CNNE scores 2 out of 10 in our fundamental rating. CNNE was compared to 99 industry peers in the Financial Services industry. CNNE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CNNE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNNE had negative earnings in the past year.
CNNE had a negative operating cash flow in the past year.
In the past 5 years CNNE reported 4 times negative net income.
CNNE had a negative operating cash flow in each of the past 5 years.
CNNE Yearly Net Income VS EBIT VS OCF VS FCFCNNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

CNNE has a Return On Assets of -30.79%. This is amonst the worse of the industry: CNNE underperforms 87.88% of its industry peers.
Looking at the Return On Equity, with a value of -38.54%, CNNE is doing worse than 84.85% of the companies in the same industry.
Industry RankSector Rank
ROA -30.79%
ROE -38.54%
ROIC N/A
ROA(3y)-13.01%
ROA(5y)-1.54%
ROE(3y)-15.27%
ROE(5y)-1.43%
ROIC(3y)N/A
ROIC(5y)N/A
CNNE Yearly ROA, ROE, ROICCNNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

The Gross Margin of CNNE (15.78%) is worse than 62.63% of its industry peers.
CNNE's Gross Margin has improved in the last couple of years.
CNNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.75%
GM growth 5Y3.28%
CNNE Yearly Profit, Operating, Gross MarginsCNNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

More info and screens

5

2. Health

2.1 Basic Checks

CNNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CNNE has less shares outstanding
CNNE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CNNE is higher compared to a year ago.
CNNE Yearly Shares OutstandingCNNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CNNE Yearly Total Debt VS Total AssetsCNNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.79, we must say that CNNE is in the distress zone and has some risk of bankruptcy.
CNNE has a Altman-Z score of 1.79. This is in the better half of the industry: CNNE outperforms 71.72% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that CNNE is not too dependend on debt financing.
CNNE has a Debt to Equity ratio of 0.05. This is amongst the best in the industry. CNNE outperforms 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 1.79
ROIC/WACCN/A
WACC7.97%
CNNE Yearly LT Debt VS Equity VS FCFCNNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CNNE has a Current Ratio of 2.03. This indicates that CNNE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CNNE (2.03) is better than 75.76% of its industry peers.
CNNE has a Quick Ratio of 2.03. This indicates that CNNE is financially healthy and has no problem in meeting its short term obligations.
CNNE has a Quick ratio of 2.03. This is in the better half of the industry: CNNE outperforms 76.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 2.03
CNNE Yearly Current Assets VS Current LiabilitesCNNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

CNNE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -60.71%.
Looking at the last year, CNNE shows a decrease in Revenue. The Revenue has decreased by -6.86% in the last year.
CNNE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -15.81% yearly.
EPS 1Y (TTM)-60.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-468.18%
Revenue 1Y (TTM)-6.86%
Revenue growth 3Y-15.21%
Revenue growth 5Y-15.81%
Sales Q2Q%-6.15%

3.2 Future

Based on estimates for the next years, CNNE will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.42% on average per year.
Based on estimates for the next years, CNNE will show a decrease in Revenue. The Revenue will decrease by -2.99% on average per year.
EPS Next Y-64.56%
EPS Next 2Y26.84%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue Next Year-5.69%
Revenue Next 2Y-5.09%
Revenue Next 3Y-2.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNNE Yearly Revenue VS EstimatesCNNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CNNE Yearly EPS VS EstimatesCNNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10 15 20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNNE. In the last year negative earnings were reported.
Also next year CNNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNNE Price Earnings VS Forward Price EarningsCNNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNNE Per share dataCNNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CNNE's earnings are expected to grow with 18.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.84%
EPS Next 3Y18.42%

More info and screens

3

5. Dividend

5.1 Amount

CNNE has a Yearly Dividend Yield of 3.38%. Purely for dividend investing, there may be better candidates out there.
CNNE's Dividend Yield is a higher than the industry average which is at 2.43.
CNNE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 3.38%

5.2 History

CNNE has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNNE Yearly Dividends per shareCNNE Yearly Dividends per shareYearly Dividends per share 2021 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

CNNE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-6.63%
EPS Next 2Y26.84%
EPS Next 3Y18.42%
CNNE Yearly Income VS Free CF VS DividendCNNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

More info and screens

CANNAE HOLDINGS INC

NYSE:CNNE (12/26/2025, 4:15:00 PM)

After market: 15.85 0 (0%)

15.85

-0.05 (-0.31%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners95.5%
Inst Owner Change-14.58%
Ins Owners13.13%
Ins Owner Change0.33%
Market Cap781.25M
Revenue(TTM)430.20M
Net Income(TTM)-466.30M
Analysts85
Price Target20.91 (31.92%)
Short Float %7.75%
Short Ratio5.17
Dividend
Industry RankSector Rank
Dividend Yield 3.38%
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP-6.63%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-17 2025-12-17 (0.15)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-808.24%
Min EPS beat(2)-1301.07%
Max EPS beat(2)-315.42%
EPS beat(4)0
Avg EPS beat(4)-525.95%
Min EPS beat(4)-1301.07%
Max EPS beat(4)-147.33%
EPS beat(8)1
Avg EPS beat(8)-508.17%
EPS beat(12)2
Avg EPS beat(12)-527.36%
EPS beat(16)3
Avg EPS beat(16)-2443.17%
Revenue beat(2)0
Avg Revenue beat(2)-0.87%
Min Revenue beat(2)-1.74%
Max Revenue beat(2)0%
Revenue beat(4)1
Avg Revenue beat(4)-0.98%
Min Revenue beat(4)-3.92%
Max Revenue beat(4)1.74%
Revenue beat(8)3
Avg Revenue beat(8)-3.05%
Revenue beat(12)3
Avg Revenue beat(12)-4.53%
Revenue beat(16)3
Avg Revenue beat(16)-6.09%
PT rev (1m)0%
PT rev (3m)-6.82%
EPS NQ rev (1m)-8.82%
EPS NQ rev (3m)-27.59%
EPS NY rev (1m)-17.79%
EPS NY rev (3m)-70.93%
Revenue NQ rev (1m)0.38%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-7.73
EYN/A
EPS(NY)-1.85
Fwd EYN/A
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)-0.94
OCFYN/A
SpS8.73
BVpS24.55
TBVpS23.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.79%
ROE -38.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.78%
FCFM N/A
ROA(3y)-13.01%
ROA(5y)-1.54%
ROE(3y)-15.27%
ROE(5y)-1.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.75%
GM growth 5Y3.28%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.54%
Cap/Sales 2.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 2.03
Altman-Z 1.79
F-Score4
WACC7.97%
ROIC/WACCN/A
Cap/Depr(3y)55.99%
Cap/Depr(5y)58.5%
Cap/Sales(3y)1.82%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-468.18%
EPS Next Y-64.56%
EPS Next 2Y26.84%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.86%
Revenue growth 3Y-15.21%
Revenue growth 5Y-15.81%
Sales Q2Q%-6.15%
Revenue Next Year-5.69%
Revenue Next 2Y-5.09%
Revenue Next 3Y-2.99%
Revenue Next 5YN/A
EBIT growth 1Y-10.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-44.01%
EBIT Next 3Y9.51%
EBIT Next 5YN/A
FCF growth 1Y34.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.68%
OCF growth 3YN/A
OCF growth 5YN/A

CANNAE HOLDINGS INC / CNNE FAQ

What is the ChartMill fundamental rating of CANNAE HOLDINGS INC (CNNE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CNNE.


Can you provide the valuation status for CANNAE HOLDINGS INC?

ChartMill assigns a valuation rating of 0 / 10 to CANNAE HOLDINGS INC (CNNE). This can be considered as Overvalued.


How profitable is CANNAE HOLDINGS INC (CNNE) stock?

CANNAE HOLDINGS INC (CNNE) has a profitability rating of 1 / 10.


Can you provide the financial health for CNNE stock?

The financial health rating of CANNAE HOLDINGS INC (CNNE) is 5 / 10.